Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
02/2003
02/13/2003US20030033618 Generation of mammalian protein in trangenic animal; obtain embryo, transform with expression vector, propagate embryo to maturity, induce lactation, recover milk, isolate membran protein
02/13/2003US20030033617 Generation of nuclear transfer embryo; obtain cells, remove nucleus from one, transfer to enucleated cell, transform with artifical chromosome, recover and monitor gene expresion in the cell
02/13/2003US20030033615 Animal model for use in the evaluation of carcinogenicity or toxigenicity of a drug or therapeutic compound
02/13/2003US20030033614 Method for identifying hormonally modulated genes
02/13/2003US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer,
02/13/2003US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders
02/13/2003US20030032184 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders
02/13/2003US20030032003 Recovering preferential cells from solution; obtain cells, transform with expression vector, express vector, detect reporter molecule, recover cells expressing reporter molecule
02/13/2003US20030031662 Delivering pituitary tumor transforming gene carboxy-terminal peptide (PTTG-C) to mammalian cell such that the PTTG-C peptide is expressed in the cell, whereby neoplastic cellular proliferation and/or transformation of the cell is inhibited
02/13/2003US20030031660 Administering to the subject a therapeutically effective amount of heparanase for inducing bone formation
02/13/2003US20030031657 Stem cells and their use in transplantation
02/13/2003CA2494304A1 Materials and methods relating to improved vaccination strategies
02/13/2003CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003CA2455890A1 Apparatus for detecting estrus in livestock
02/13/2003CA2455700A1 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003CA2455462A1 Androgen receptor knock-out transgenic animals
02/13/2003CA2454850A1 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/12/2003EP1282721A1 Prion-free transgenic ungulates
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same
02/12/2003EP1282693A1 Human coagulation factor vii variants
02/12/2003EP1282685A2 Pluripotent cells comprising allogenic nucleus and mitochondria
02/12/2003EP1282646A2 Human monoclonal antibodies to dendritic cells
02/12/2003EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
02/12/2003EP1282433A1 Transgenically produced decorin
02/12/2003CN1396805A Transgenic coat producing milk containing human granulocyte-colony stimulating factor
02/11/2003US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells
02/11/2003US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor
02/11/2003CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
02/11/2003CA2142181C Androgen regulation with dna sequences of rat probasin gene
02/06/2003WO2003010303A1 Methods of inducing differentiation of stem cells
02/06/2003WO2003010196A2 Variants and exons of the glyt1 transporter
02/06/2003WO2003010180A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals
02/06/2003WO2002040061A9 Immunocompetent animals including xenogeneic implants of mesenchymal stem cells
02/06/2003WO2002038752A8 Use of a helminth for the in vivo delivery of a medicament
02/06/2003US20030028911 Transgenic mammal capable of facilitating production of donor-specific functional immunity
02/06/2003US20030028909 Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders
02/06/2003US20030028906 Expression vector for use in the gene therapy
02/06/2003US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders
02/06/2003US20030027783 Introducing into the cell an RNA comprising a double stranded structure having nucleotide sequence which is substantially identical to part of target gene and which is derived from an endogenous template; verifying inhibition of expression
02/06/2003US20030027777 Methods for enhancing animal growth and cell proliferation by elimination of the cyclin-dependent kinase inhibitor function of p27Kip1
02/06/2003US20030027746 Useful in the development of human therapeutics and diagnostic formulations
02/06/2003US20030027337 Sequence-specific DNA recombination in eukaryotic cells
02/06/2003US20030027334 Method for generating immortal dendritic cell lines
02/06/2003US20030027224 Monitoring immunosuppressive activity of compound; obtain sample containing calmodulin dependent kinase, incubate with substrate, expose to modulator, monitor phosphorylation, reduction in phosphorylation indicates suppressive activity
02/06/2003US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
02/06/2003US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
02/06/2003US20030024482 Programmable electronic maze for use in the assessment of animal behavior
02/06/2003CA2454183A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals
02/06/2003CA2452256A1 Methods of inducing differentiation of stem cells
02/05/2003EP1281775A2 Identification and use of molecules implicated in pain
02/05/2003EP1281765A1 Antisense type gene trap vector
02/05/2003EP1281078A1 Methods for screening and identifying host pathogen defense genes
02/05/2003EP1280911A2 Regulatory nucleic acid sequences of the ABC1 gene
02/05/2003EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
02/05/2003EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
02/05/2003EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
02/05/2003EP1280905A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene carboxy terminal peptides
02/05/2003EP1280903A2 Ph domain-interacting protein
02/05/2003EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
02/05/2003EP1280898A1 Modified es cells and es cell-specific gene
02/05/2003EP1280827A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
02/05/2003EP1280465A2 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
02/05/2003EP1280404A2 Model for neurodegenerative disease
02/05/2003EP0871463B1 Regulation of eating behavior
02/04/2003USRE37978 Myocardial grafts and cellular compositions
02/04/2003US6515199 Gene transfer in poultry by introduction of embryo cells in ovo
02/04/2003US6515197 Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide
02/04/2003US6515196 Hereditary postprandial hypertriglyceridemic rabbit model
02/04/2003US6514939 Mutants of atrial natriuretic factor that are protective for stroke
02/04/2003US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
02/04/2003US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines
02/04/2003US6514752 Homologous recombination for universal donor cells and chimeric mammalian hosts
02/04/2003US6514747 Agouti polynucleotide compositions and methods of use
02/04/2003US6514705 Screening heredity of preferential shellfish; obtain shellfish, extract mitochondrial nucleotide sequences, sequence nucleotide sequence, compare to other shellfish
02/03/2003WO2002016548A2 Novel g protein-coupled receptor
02/03/2003CA2418130A1 Novel g protein-coupled receptor
01/2003
01/30/2003WO2003008574A1 Mutations in ion channels
01/30/2003WO2003008554A2 Methods and compositions for cell therapy
01/30/2003WO2003008455A1 Activity monitor molecules for g-protein trimer
01/30/2003WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
01/30/2003WO2003007705A1 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same
01/30/2003WO2003007701A2 Aquaculture of marine worms
01/30/2003WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
01/30/2003WO2002051355A3 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action
01/30/2003WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
01/30/2003WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same
01/30/2003WO2002017858A3 Role of fosb in bone formation
01/30/2003WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
01/30/2003US20030024002 Method of preparing a somatic cell for nuclear transfer
01/30/2003US20030024001 Animal models for use in the treatment of psychological and nervous system disorders
01/30/2003US20030024000 Animal models for use in the treatment of injuries and psoriasis
01/30/2003US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease
01/30/2003US20030023995 Animal model for use in the diagnosis and treatment of cell proliferative and nervous system disorders
01/30/2003US20030023994 Assay for toxin induced neuronal degeneration and viability in C. elegans
01/30/2003US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
01/30/2003US20030023990 Jnk3 modulators and methods of use
01/30/2003US20030023034 p27 (Kip1) -FKBP-12 protein complexes
01/30/2003US20030022375 Expression vector for use as tool in gene therapy
01/30/2003US20030022287 Non aggregating fluorescent proteins and methods for using the same